Gupta Preeya K, Periman Laura M, Lain Edward, Donnenfeld Eric, Hovanesian John, Kim Terry, Trattler William, Yeu Elizabeth, Holland Edward
Triangle Eye Consultants, Durham, NC, USA.
Periman Eye Institute, Seattle, WA, USA.
Clin Ophthalmol. 2021 Nov 9;15:4399-4404. doi: 10.2147/OPTH.S327407. eCollection 2021.
Meibomian glands are modified oil-producing glands that produce meibum and can become dysfunctional and negatively affect the lipid layer in the tear film, resulting in ocular surface diseases such as evaporative dry eye. Abnormal keratin production and aggregation at the meibomian gland orifice has been implicated in the pathogenesis of meibomian gland dysfunction (MGD). Current treatments largely ignore the role of keratin proteins. This review paper synthesizes various publications on hyperkeratinization and its role in MGD pathogenesis and proposes a novel treatment strategy for MGD that involves the use of keratolytic agents commonly used in dermatological treatments.
睑板腺是一种特殊的产油腺体,能分泌睑脂,其功能失调会对泪膜中的脂质层产生负面影响,进而引发诸如蒸发型干眼等眼表疾病。睑板腺开口处异常的角蛋白生成和聚集与睑板腺功能障碍(MGD)的发病机制有关。目前的治疗方法很大程度上忽视了角蛋白的作用。这篇综述文章综合了各种关于角化过度及其在MGD发病机制中作用的出版物,并提出了一种针对MGD的新治疗策略,即使用皮肤科治疗中常用的角质溶解剂。